After a tough bout with inflation that wasn't fully paired with additional pricing power, The Clorox Company (NYSE: CLX) looks like it's finally on the mend. It could take months (if not quarters) before rising input costs finally fall to the Fed's long-term target of around 2%. Right now, Clorox is priced more like a growth stock even though basic consumer goods companies like it are almost exclusively considered value names.